Research Technician - Tumoral and Stromal Chemoresistance Group at Oncobell Call

REF. 26-024_SS_DG

About the research group

The Molleví group investigates how cells and components of the tumor microenvironment—especially cancer-associated fibroblasts—affect tumor development, metastasis, and resistance to chemotherapy in colorectal cancer. Their work focuses mainly on liver metastases and on understanding the histological growth patterns and stromal factors that influence prognosis and treatment response. The ultimate goal is to identify biomarkers and develop new therapeutic strategies to overcome treatment resistance.

About the role

Spatial analyses in multiplex antibody panels.

Job requirements

Professional experience

• Experience with spatial analyses in multiplex antibody panels.
• Understanding of the tumor microenvironment, including the role of cancer-associated fibroblasts in tumor progression and chemoresistance.
• Familiarity with colorectal cancer liver metastases and histological growth patterns.
• Interest or experience in biomarker identification and exploring how stromal factors influence treatment response.
• Ability to contribute to a collaborative research team focused on tumor and stromal chemoresistance.

Education and training

•  Higher Technical Diploma in Biological Sciences 

Technical & soft skills

• Digital pathology, MACSima multiplex staining (mandatory)

Languages

• Good command of the English language

We will value, but not required

• Advanced Degree in Biological Sciences will be valued

What do we offer

•  No. of positions: 1
•  Estimated start date: 01/04/2026
•  Contract duration: 3 months
•  Estimated annual gross salary: Salary is commensurate with qualifications and consistent with our pay ranges.
•  You will be part of a multicultural team. We have a fun loving and friendly international work environment.
•  Flexible working schedule - We know you have a life outside of work and we will work with you to make sure it's kept that way.
•  Possibility to work some days in remote -Teleworking
•  26 working days of holiday per year
•  System of accumulated hours for employees, from 88 to 104 hours depending on the year (11 to 13 working days), to attend to personal matters.
•  Paid leave package
•  Benefits of constant training are offered
•  We offer and promote diverse and inclusive conditions. Applicants are made free from any discrimination. Specifically IDIBELL works to improve gender equality in all areas with the aim of achieving gender balance, but maintaining the most scrupulous respect to any choice at the level of gender identity. Please express yourself freely, safely and non-binarily, if that's the case.

Deadline: Please submit your application by  25/03/2026

Data protection notice

In compliance with the obligations established in the General Regulation of Data Protection (RGPD), which is the Regulation (EU) 2016/679 of the Parliament and of the Council, of April 27, 2016, and the Organic Law 3/2018, of December 5, Protection of Personal Data and guarantee of digital rights, it is reported that the Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), CIF G58863317, with address Av. Granvia de l'Hospitalet, 199-203, 08908, L'Hospitalet de Llobregat, will process your personal data, as the controller, to apply for the position, maintain communication concerning the status of the candidature, to access the delivered CV; to compare that your data is in accordance with the offers announced by IDIBELL and to verify, where appropriate, that the information provided is accurate. You can find more information in our Privacy Policy at https://idibell.cat/en/privacy-policy-2/, request more information about the data processing carried out and exercise your rights of access, rectification, deletion, opposition, portability, limitation of processing by sending a request at email: dataprotection@idibell.cat. If you consider that you have not obtained satisfaction in exercising your rights, you may submit a claim to Catalan Data Protection Authority.

Our institute

IDIBELL is a research center that integrates the biomedical research of the Bellvitge University Hospital (HUB), the Catalan Institute of Oncology (ICO), and the University of Barcelona in the Bellvitge Campus (UB), and the Viladecans Hospital (HV). The research focuses of IDIBELL are cancer, neuroscience, translational medicine and regenerative medicine. Research, innovation and society are the pivots on which researchers work every day in order to improve the quality of life of citizens.

Observations:

The 'HR Excellence in Research' award represents IDIBELL’s commitment to the implementation of Human Resources policies, which oversee the attracting and development of talent in an open, transparent, and based on personal merit, in alignment with the principles of the European Charter for Researchers and the Code of Conduct for the Recruitment Researchers (Charter and Code).

IDIBELL is committed to the principles of the Code of Conduct for the Recruitment of Researchers of the European Commission and the implementation of open, transparent and merit-based recruitment (OTMR).